Effects of Caffeine on Chess Performance and Cognitive Function in Professional Chess Players
St. Louis University · NCT07641335
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 12
- US sites recruiting
- 1
- Study start
- August 25, 2026
- Record last updated
- September 30, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will examine whether caffeine improves cognitive and competitive performance in professional chess players during tournament-style games. In a randomized double-blind crossover design, participants will complete two experimental sessions in which they consume either caffeinated coffee or decaffeinated coffee before playing a standardized chess match. Cognitive performance will be assessed using attention and reaction-time tests, including the Stroop Test, Trail Making Test, and Puzzle Rush task. Chess performance outcomes such as move accuracy, time management, and error rates will also be evaluated. The study aims to determine whether moderate caffeine intake enhances focus, alertness, and decision-making during prolonged competitive chess play.
Being studied: Caffeinated Coffee; Decaffeinated Coffee Placebo
Conditions: Cognitive Performance; Attention; Reaction Time; Caffeine
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Male and female professional chess players aged 18-50 years
- Current Fédération Internationale des Échecs (FIDE) standard rating between 2300 and 2600 Elo, or achievement of a standard FIDE rating within this range during the previous 12 months
- Habitual caffeine consumers consuming ≤2 cups of coffee per day
- Willingness to comply with all study procedures and study visits
- Ability to provide written informed consent
Exclusion Criteria
- Non-caffeine users
- Habitual caffeine intake exceeding 2 cups of coffee per day
- Cardiovascular disorders
- Metabolic disorders
- Psychiatric disorders
- Pregnancy or breastfeeding
- Current smoking
- Shift workers
- Use of psychoactive medications
- Participation in another clinical trial within the previous 3 months
- Known allergy or intolerance to milk proteins, dairy products, or soy
- Known red-green color blindness or other color vision deficiencies that may interfere with Stroop Test performance
Recruiting US locations
Saint Louis University
St Louis, MO 63104
Site contact: Hossein Rafiei, PhD · 314-977-8675 · hossein.rafiei@health.slu.edu
Study contacts (from the official record)
- Hossein Rafiei, PhD · 13149778675 · hossein.rafiei@health.slu.edu
Similar studies in Missouri
All healthy volunteers studies in Missouri →- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 9 other US sites
- Eligibility basics
- Ages 50–75
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Kansas City, MO + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- St Louis, MO + 14 other US sites
- Eligibility basics
- Ages 2 mo–1